on September 6, 2021 Categories COVID-19InflammationPediatricSars-Cov-2 DateSeptember 6, 2021 Frontiers in Pediatrics 06 September 2021 Share Related postsAugust 18, 2020Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19Read moreDecember 31, 2020Vascular Endothelial Glycocalyx Damage in COVID-19Read moreJune 20, 2022Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the MICROCODE studyRead more
